Form D · Biotechnology

Inspira Technologies OXY B.H.N. Ltd

Ra'anana, L3 · CIK 0001837493

Offering snapshot reported Jan 7, 2025 · SEC filing

Reported sold: $8.3M
Investors reported: 12
Minimum accepted: $0
First sale: Dec 27, 2024

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jan 7, 2025	Initial	$8,295,686	No comparison	12	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $153K
Finders' fees: $0
Form D file number: 021-534476

The total offering amount reflects the total gross proceeds to be received by the company assuming cash exercise of all warrants issued to the accredited investor in the private placement under Rule 506(b).

The sales commissions include commissions from the potential exercise of all warrants issued to the investors in the transaction.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Dawson James Securities, Inc.	000130645

Source: Form D, filed Jan 7, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Lior Amit	Director
Dagi Ben Noon	Director, Executive
Benad Goldwasser	Director
Joe Hayon	Director, Executive
Tal Parnes	Director
Limor Rozen	Director
Avi Shabtai	Executive
Yafit Tehila	Executive
Daniella Yehezkely Hayon	Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

2 Ha Tidhar St.
Ra'anana, L3, 4366504